GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000059 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 30, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
156,111
Total Value
$391,565.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 26, 2026 | Exercise/Conversion | 2,037 | $2.20 | $4,481.40 | 2,037 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 26, 2026 | Sale | 2,037 | $5.00 | $10,185.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 26, 2026 | Exercise/Conversion | 2,533 | $2.50 | $6,332.50 | 2,533 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 26, 2026 | Sale | 2,533 | $5.00 | $12,665.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 29, 2026 | Exercise/Conversion | 47,467 | $2.50 | $118,667.50 | 47,467 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 29, 2026 | Sale | 47,467 | $5.04 | $239,233.68 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | Jun 26, 2026 | Exercise/Conversion | 2,037 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Jun 26, 2026 | Exercise/Conversion | 2,533 | $0.00 | $0.00 | 47,467 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Jun 29, 2026 | Exercise/Conversion | 47,467 | $0.00 | $0.00 | 0 | Direct | โ | View Details |